| Axiom edition
6
Autumn 2011
Engaging e-patients: How to steer pharma
to safety
Value-based pricing in the UK: Developing
an evaluation framework for burden of illness
Improving performance for pharmacovigilance
inspections
click
here to view
|
Axiom edition
5
Spring 2011
Focus on real-world data, including EU
and US stakeholder research
In mint condition, the economic benefits
of maintaining a
healthy workforce
China: access all areas? Reimbursement
opportunities in China
click
here to view |
Axiom edition
4
Spring 2010
Focus on Talent management
Implementing patient access schemes in
the UK
How can risk minimisation tools be improved?
An industry perspective
Innovation in patient compliance
Opinion on value demonstration
click
here to view |
Axiom Digest
2009
A collection of the best articles from
Pope Woodhead's bi-annual newsletter
click
here to view |
Axiom edition
3
Spring 2009
The who, what, when and how of
local EU payer engagement
Registries: Real-world knowledge for competitive
advantage
Has clinical trial disclosure helped the
average patient?
An industry perspective
Focus on commercial innovation and risk
sharing
click
here to view |
Axiom edition
2
Spring/Summer 2008
5 steps to an integrated value
proposition
PW’s ‘digital conversation’
risk
minimisation tool
Success factors for managing
key opinion leaders
Industry and payer perspectives
on cost-effectiveness evaluation
click
here to view |
| Toolkit
for patients’ organisations
Collaborative initiative to support groups
in developing effective relationships with
key stakeholders
Pharmaceutical Market Europe September
2011 |
Partnering
patients
In this article Dr Beverly Barr
discusses the long-term benefits of pharma engaging with patient
organisations. |
Lifestyle
advice and drug therapy post-myocardial infarction: a survey
of UK current practice. |
| Communicating
product
value to local payers is
a new challenge
Pharmaceutical
Marketing Europe
March/April 2009
click here to view |
Innovative
schemes give reassurance to payers in exchange for market access
Pharmaceutical
Marketing Europe
May/June 2009
click
here to view |
| Real
Time Post Marketing Evaluation
of Therapeutic Risk Management
Plans(RMPs)
– A Novel Pharmacoepidemiological Tool?
Pharmacoepidemiology and
Drug Safety 2008
click
here to view |
Better awareness and
implementation of
pharmacovigilance and
risk management planning
is needed within the European Pharmaceutical Industry
click
here to view |
